Hengehold Capital Management LLC Lowers Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Hengehold Capital Management LLC reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 4.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 985 shares of the healthcare conglomerate’s stock after selling 47 shares during the period. Hengehold Capital Management LLC’s holdings in UnitedHealth Group were worth $487,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Richelieu Gestion SA acquired a new position in UnitedHealth Group during the 4th quarter worth approximately $26,000. CGC Financial Services LLC lifted its position in UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 50 shares in the last quarter. True Wealth Design LLC acquired a new position in UnitedHealth Group during the 4th quarter worth approximately $31,000. LFA Lugano Financial Advisors SA lifted its position in UnitedHealth Group by 148.1% during the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after acquiring an additional 40 shares in the last quarter. Finally, Transcendent Capital Group LLC acquired a new position in UnitedHealth Group during the 4th quarter worth approximately $40,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

UNH has been the topic of several analyst reports. Truist Financial restated a “buy” rating and set a $600.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 17th. Robert W. Baird began coverage on UnitedHealth Group in a report on Thursday, May 30th. They set an “outperform” rating and a $597.00 price objective on the stock. Royal Bank of Canada lowered their price target on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a report on Wednesday, April 17th. Wells Fargo & Company lowered their price target on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a report on Monday, April 8th. Finally, Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Three equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $579.74.

UnitedHealth Group Stock Performance

UNH stock traded up $7.64 during trading on Friday, reaching $494.08. 4,736,158 shares of the company’s stock were exchanged, compared to its average volume of 4,153,512. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70. The company’s fifty day moving average price is $498.30 and its 200-day moving average price is $502.61. The firm has a market cap of $454.75 billion, a PE ratio of 30.61, a P/E/G ratio of 1.40 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company’s revenue was up 8.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $6.26 earnings per share. On average, research analysts expect that UnitedHealth Group Incorporated will post 27.57 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th were issued a $2.10 dividend. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date of this dividend was Monday, June 17th. This represents a $8.40 annualized dividend and a dividend yield of 1.70%. UnitedHealth Group’s dividend payout ratio is 51.34%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.